These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 163093)

  • 21. Apparent correlation between adenosine 3':5' cyclic monophosphate levels and malignancy in somatic cell hybrids.
    Tisdale MJ; Phillips BJ
    Exp Cell Res; 1974 Sep; 88(1):111-20. PubMed ID: 4371521
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition of thymidylate synthetase of Walker carcinoma by chlorambucil. A possible mechanism of action.
    Srinivasan SK; Gupta VS; Howarth RE
    Biochem Pharmacol; 1977 Jun; 26(11):1027-32. PubMed ID: 880254
    [No Abstract]   [Full Text] [Related]  

  • 23. Adenosine-3',5'-cyclic monophosphate levels and adenosine-3',5'-cyclic monophosphate phosphodiesterase activity in metastasizing and nonmetastasizing rat mammary carcinomas.
    Chatterjee SK; Kim U
    J Natl Cancer Inst; 1975 Jan; 54(1):181-6. PubMed ID: 163315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of the toxicity and antitumour activity of alkylating drugs by steroids.
    Shepherd R; Harrap KR
    Br J Cancer; 1982 Mar; 45(3):413-20. PubMed ID: 7073935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A method of primary selection of antitumor agents].
    Karaivanova MKh
    Vopr Onkol; 1971; 17(2):62-6. PubMed ID: 5567711
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of chemotherapy on human tumor heterografts and lymphocytes in athymic mice].
    Bukharova IK; Osokina LI; Milovanova TI
    Biull Eksp Biol Med; 1987 May; 103(5):610-3. PubMed ID: 3593937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate levels, cyclases, and phosphodiesterases in Morris hepatomas and liver.
    Hickie RA; Thompson WJ; Strada SJ; Couture-Murillo B; Morris HP; Robison GA
    Cancer Res; 1977 Oct; 37(10):3599-606. PubMed ID: 20224
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on the mechanism of resistance to alkylating agents of three ascites tumours in the rat.
    Poynter RW
    Biochem Pharmacol; 1970 Apr; 19(4):1387-97. PubMed ID: 4327763
    [No Abstract]   [Full Text] [Related]  

  • 29. Membrane transport of alkylating agents.
    Goldenberg GJ; Begleiter A
    Pharmacol Ther; 1980; 8(2):237-74. PubMed ID: 6992155
    [No Abstract]   [Full Text] [Related]  

  • 30. The need for additional alkylating agents.
    Connors TA
    Cancer Res; 1969 Dec; 29(12):2433-7. PubMed ID: 5369691
    [No Abstract]   [Full Text] [Related]  

  • 31. Chemotherapeutic effects of compound 593A (NSC-135758) on mouse leukemias and some transplanted animal tumors.
    Tarnowski GS; Schmid FA; Hutchison DJ; Stock CC
    Cancer Chemother Rep; 1973 Feb; 57(1):21-7. PubMed ID: 4704098
    [No Abstract]   [Full Text] [Related]  

  • 32. Feedback inhibition by 6-methylthioinosine 3',5'-cyclic monophosphate in tumor cells resistant to the nucleoside.
    Epps D; Chang IM; Sherwood E; Kimball AP
    Proc Soc Exp Biol Med; 1975 Dec; 150(3):578-80. PubMed ID: 174138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The growth of human tumours in immunosuppressed mice and their response to chemotherapy.
    Berenbaum MC; Sheard CE; Reittie JR; Bundick RV
    Br J Cancer; 1974 Jul; 30(1):13-32. PubMed ID: 4213444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biologic characterization of the subcutaneously implanted Lewis lung tumor.
    Mayo JG
    Cancer Chemother Rep 2; 1972 Nov; 3(1):325-30. PubMed ID: 4660735
    [No Abstract]   [Full Text] [Related]  

  • 35. Norepinephrine-sensitive properties of C-6 astrocytoma cells.
    Browning ET; Schwartz JP; Breckenridge BM
    Mol Pharmacol; 1974 Jan; 10(1):162-74. PubMed ID: 4136180
    [No Abstract]   [Full Text] [Related]  

  • 36. The role of WR-2721 in radiotherapy and/or chemotherapy.
    Yuhas JM; Spellman JM; Culo F
    Cancer Clin Trials; 1980; 3(3):211-6. PubMed ID: 6254681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Independence of pituitary tumor-mediated suppression of growth hormone secretion and cyclic 3',5'-adenosine monophosphate production.
    MacLeod RM; Lehmeyer JE
    Cancer Res; 1973 Apr; 33(4):843-8. PubMed ID: 4348775
    [No Abstract]   [Full Text] [Related]  

  • 38. [Histochemical studies on irradiated transplantation tumors in rats].
    Hecker D
    Radiobiol Radiother (Berl); 1972; 13(3):379-91. PubMed ID: 4262950
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of dibutyryl cyclic adenosine 3',5'-monophosphate on in vivo growth of Walker 256 carcinoma: isolation of responsive and unresponsive cell populations.
    Choe-Chung YS; Gullino PM
    J Natl Cancer Inst; 1974 Mar; 52(3):995-6. PubMed ID: 4363699
    [No Abstract]   [Full Text] [Related]  

  • 40. Increased antitumour activity of chlorambucil following pretreatment with inducers of drug-metabolizing enzymes.
    Hill BT; Douglas ID; Grover PL
    Biochem Pharmacol; 1973 May; 22(9):1083-9. PubMed ID: 4695667
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.